| Institution: | 1. Lymphocyte Development Group, MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK;2. Epigenetic Mechanisms of Toxicity, MRC Toxicology Unit, University of Cambridge, Downing Street, Cambridge, CB2 3EH, UK;1. Microvida Laboratory for Medical Microbiology and Immunology, St. Elizabeth Hospital, Tilburg, The Netherlands;2. Science Department of University College Roosevelt, Middelburg, The Netherlands;1. Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK;2. Department of Infectious Diseases, King''s College London, Faculty of Life Sciences and Medicine, London SE1 9RT, UK;3. Randall Division of Cell and Molecular Biophysics, King''s College London, London SE1 9RT, UK;1. Department of Biochemistry, School of Medicine, University of Costa Rica, 11501-2060 San José, Costa Rica;2. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA;3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;4. Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA |
